- Home
- NVOS vs NTBL Comparison
NVOS vs NTBL Comparison
Compare NVOS & NTBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVOS
- NTBL
- Stock Information
- Founded
- NVOS 2000
- NTBL 2000
- Country
- NVOS United States
- NTBL United States
- Employees
- NVOS N/A
- NTBL N/A
- Industry
- NVOS Assisted Living Services
- NTBL Biotechnology: Pharmaceutical Preparations
- Sector
- NVOS Health Care
- NTBL Health Care
- Exchange
- NVOS Nasdaq
- NTBL Nasdaq
- Market Cap
- NVOS 5.6M
- NTBL 4.6M
- IPO Year
- NVOS 2017
- NTBL N/A
- Fundamental
- Price
- NVOS $0.23
- NTBL $0.25
- Analyst Decision
- NVOS
- NTBL Buy
- Analyst Count
- NVOS 0
- NTBL 2
- Target Price
- NVOS N/A
- NTBL $5.00
- AVG Volume (30 Days)
- NVOS 326.8K
- NTBL 8.1M
- Earning Date
- NVOS 12-12-2024
- NTBL 11-12-2024
- Dividend Yield
- NVOS N/A
- NTBL N/A
- EPS Growth
- NVOS N/A
- NTBL N/A
- EPS
- NVOS N/A
- NTBL N/A
- Revenue
- NVOS $13,516,958.00
- NTBL $313,000.00
- Revenue This Year
- NVOS N/A
- NTBL N/A
- Revenue Next Year
- NVOS N/A
- NTBL N/A
- P/E Ratio
- NVOS N/A
- NTBL N/A
- Revenue Growth
- NVOS 1102.98
- NTBL 3812.50
- 52 Week Low
- NVOS $0.20
- NTBL $0.22
- 52 Week High
- NVOS $3.45
- NTBL $4.24
- Technical
- Relative Strength Index (RSI)
- NVOS 38.13
- NTBL 35.14
- Support Level
- NVOS $0.20
- NTBL $0.28
- Resistance Level
- NVOS $0.31
- NTBL $0.37
- Average True Range (ATR)
- NVOS 0.03
- NTBL 0.06
- MACD
- NVOS 0.00
- NTBL -0.01
- Stochastic Oscillator
- NVOS 27.18
- NTBL 6.26
About NVOS Novo Integrated Sciences Inc.
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services which generates majority of the revenue, and product sales.
About NTBL Notable Labs Ltd.
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.